Please login or register first to view this content.
Ophthalmic Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Growing Evidence Links Pentosan Polysulfate Sodium, Maculopathy
ACR: Risk Factors ID’d for Hydroxychloroquine-Related Retinopathy
October 2021: 5 Notable Drug Approvals
Tyrvaya Nasal Spray Now Available for Dry Eye Disease
FDA Approves First Eye Drop to Treat Presbyopia
USPSTF: Evidence Lacking for Screening Seniors for Visual Acuity
USPSTF: Evidence Lacking for Open-Angle Glaucoma Screening
Xipere for Suprachoroidal Use Approved for Macular Edema Associated With Uveitis
Susvimo Approved for Wet Age-Related Macular Degeneration
Digital Therapeutic Approved for Vision Improvement in Children With Amblyopia
Tyrvaya Nasal Spray Approved for Dry Eye Disease
Dextenza Approved for Ocular Itching Associated With Allergic Conjunctivitis
First Biosimilar to Lucentis Gets FDA Approval
Tebentafusp Gets Priority Review for Metastatic Uveal Melanoma
NSAID Eye Drops May Suffice for Cataract Surgery Prophylaxis
FDA Approves Generic Version of Durezol
Intravitreal Methotrexate Gets Orphan Drug Status for Retinitis Pigmentosa
Faricimab Gets Priority Review for Wet AMD, Diabetic Macular Edema
